Harpoon Therapeutics, Inc.
HARPDelisted Mar 11, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708493
Harpoon Therapeutics, Inc. was delisted on Mar 11, 2024; its insiders filed their last Form 4 on Mar 11, 2024; 41 institutions reported holding it in 13F filings for Q4 2023, worth $175.5M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Harpoon Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 85 | 93 | +8 |
| Shares | 28.7M | 25.8M | −2.88M (−10.0%) |
| Value | $357.3M | $203.9M | −$153.4M (−42.9%) |
New holders (22)
Institutions that held Harpoon Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (14)
Institutions that held Harpoon Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Logos Global Management LP | 800,000 | $11.1M |
| Aquilo Capital Management, LLC | 712,674 | $9.88M |
| Sectoral Asset Management Inc | 580,759 | $8.05M |
| VR Adviser, LLC | 512,005 | $7.10M |
| Bailard, Inc. | 118,878 | $1.65M |
| Rafferty Asset Management, LLC | 59,549 | $826.0K |
| Acadian Asset Management LLC | 22,933 | $318.0K |
| Jane Street Group, LLC | 13,848 | $192.0K |
| Russell Investments Group, Ltd. | 12,636 | $175.0K |
| Manufacturers Life Insurance Company, The | 12,036 | $167.0K |
| XTX Topco Ltd | 10,898 | $151.0K |
| ProShare Advisors LLC | 10,697 | $148.0K |
| O'Shaughnessy Asset Management, LLC | 624 | $9.00K |
| Toth Financial Advisory Corp | 120 | $2.00K |